USPTO serial 88320499
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | (Based on 44(e)) Measuring, detecting and monitoring instruments, measuring, detecting and monitoring devices, and measuring, detecting and monitoring regulators, for preparing, processing and evaluating diagnostic samples, for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Sensors and detectors, in particular UV fluorescence and chemiluminescence detectors for preparing, processing and evaluating diagnostic samples; Apparatus for recording, transmission and reproduction of diagnostic data, sound and images, in particular cameras, microscopes, photometers, microplate photometers, enzyme-linked immunosorbent assay readers, photomultipliers, and microplate readers; (Based on Use in Commerce) Recorded software, downloadable software, and software recorded on media, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer | ACTIVE | Nov 20, 2018 |
| 042 | (Based on 44(e)) Scientific services and research, in particular scientific services for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Industrial analysis in the nature of analysis of industrial and medical fluids and reagents; Scientific research services, in particular research services for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Design and development of computer hardware and software, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; (Based on Use in Commerce) Providing on-line non-downloadable software, namely, laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer | ACTIVE | Nov 20, 2018 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 11, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 16, 2021 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Jun 15, 2021 | IUAA | USE AMENDMENT ACCEPTED | — |
| Apr 22, 2021 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Apr 22, 2021 | IUAF | USE AMENDMENT FILED | — |
| Apr 21, 2021 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Mar 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 25, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 17, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 17, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 17, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 17, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 17, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 6, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 6, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 6, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 6, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 6, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 6, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 6, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 6, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 7, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 4, 2019 | NWAP | NEW APPLICATION ENTERED | — |